Assertio therapeutics posts fourth-quarter loss per share of $2.65

Assertio therapeutics announces fourth-quarter and full-year 2019 financial results.assertio therapeutics inc - qtrly loss per share $2.65.assertio therapeutics inc - qtrly adjusted loss per share $0.14.assertio therapeutics inc - qtrly total revenues $59.2 million.
ASRT Ratings Summary
ASRT Quant Ranking